Best Doctors in Turkey — Get an Online Consultation

Education and Expertise

(1994 – 2000) - GATA Faculty of Medicine Ankara

(2003 – 2007) - GATA Medical Faculty Pediatrics and Diseases

(2008 -2011) - Ankara University Pediatric Endocrinology

(03.03.2014) - Associate Professorship, Pediatric Endocrinology

(17.07.2019) - Professorship, Istinye University Faculty of Medicine

Experience

(2001 – 2003) - Special Forces Command/Ankara

(2007 – 2008) - Etimesgut Military Hospital/Ankara

(2011 – 2013) - GATA Medical Faculty Hospital/Ankara

(2013-2015) - GATA Haydarpasa Training Hospital/Istanbul

(05.2015-09.10.2017) - May 2015-09.10.2017 - Süleymaniye Gynecology and Pediatrics Training and Research Hospital/Istanbul

(07.2015 – 01.2016) - Suleymaniye Gynecology and Pediatrics Training and Research Hospital Pediatrics Administrative Responsibility/Istanbul

01.2016 - 09.11.2017 - Suleymaniye Gynecology and Pediatrics Training and Research Hospital Pediatric Clinic Education Responsibility / Istanbul

(03.03.2016 - 30.10.2017) - Süleymaniye Gynecology and Pediatrics Training and Research Hospital Management

(2017-2020) - Istinye University Faculty of Medicine Faculty Member

(2020-Present) - Istanbul Aydın University Faculty of Medicine Faculty Member

(20.10.2020-Present) - Head of Department of Child Health and Diseases, Faculty of Medicine, Istanbul Aydın University

Courses and Certificates

2001 - Flight Doctor Course

2010 - Project Management Training Course

2013 - Basic Epidemiology course

2018 - Trainer Training Course

Professional Memberships

Pediatric Endocrinology and Diabetes Association

European Society of Pediatric Endocrinology (ESPE)

Istanbul Medical Chamber

Awards

İhsan Turan, Ian Hutchins, Bülent Hacıhamdioğlu, Leman Damla Kotan, Fatih Gürbüz, Mehmet Taştan, Ayça Ulubay, Eda Mengen, Bilgin Yüksel, Susan Wray, Ali Kemal Topaloğlu. CCDC141 Mutation in idiopathic hypogonadotropic hypogonadism. XVI. First Prize in Oral Presentation at the National Pediatric Endocrine and Diabetes Congress.

Bülent Hacıhamdioğlu, Gönül Öçal, Merih Berberoğlu, ZeynepŞıklar, Ercan Tutar, Suat Fitöz, Gökhan Nergizoğlu, Şenay Savaş Erdeve, Emine Çamtosun. Control of premature microvascular aging and cardiovascular performance in obese adolescents. XVI. was held in Samsun on 6-10 November 2012. Second Prize in Oral Presentation at the National Pediatric Endocrine and Diabetes Congress.

Z. Siklar, G. Ocal, M. Berberoglu, B. Hacıhamdioğlu, Ş. Savas Erdeve, Y. Egin, N. Akar. Control of hypercoagulability caused by obesity in children with endothelial microparticle level and thrombin generation test, and the relationship between risk and metabolic parameters. First Prize in Oral Presentation at the 55th Turkish National Pediatrics Congress held in Antalya on 12-16 October 2011

Z. Şıklar, V. Topçu, P. Kocaay, M. Berberoğlu, B. Hacıhamdioğlu, S.S. Erdeve, H.R. Ilgin, A. Tükün, G. Öcal. Clinical Characteristics of Our Cases with Mutation in the Androgen Receptor Gene. XVI. was held in Samsun on 6-10 November 2012. First Prize in Oral Presentation at the National Pediatric Endocrine and Diabetes Congress.

Areas of Interests

• Cornea
   
• Refractive Surgery
   
• Contact Lens
   
• Oculoplasty
   
• Glaucoma
   
• Medical Retina
   
• Retinopathy of Prematurity
   
• Cataract
   
• Corneal Transplant

Education:

• 2010- 2015 Uludağ University Faculty of Medicine Department of Ophthalmology - Assistant
• 2002-2009 Uludağ University Faculty of Medicine Bursa - Student
• 1999-2002 Private Çukurova Bilfen Science High School -Adana

Experience:

• Liv Hospital Ulus
• Yeniyüzyıl University Private Gaziosmanpaşa Hospital
• Surp Pırgiç Armenian Hospital
   
• Şişli Hamidiye Etfal Education and Research Hospital

Prof. Dr. Mert Yilmaz is a board-certified cardiovascular surgeon with more than 30 years of experience. He specializes in both adult and pediatric cardiac surgery. He graduated from Istanbul University in 1988. He completed his residency at Uludag University and received further training at the Royal South Hants Hospital in the UK.

Dr. Yilmaz was among the first in Turkey to perform endovascular repair of abdominal aneurysms. He completed the country’s second case. He has led cardiovascular surgery departments at leading hospitals. He now heads the department at Kadıköy Florence Nightingale Hospital. He is also a full professor at Halic University and an international member of the Society of Thoracic Surgeons (USA).

Dr. Yilmaz has published over 50 peer-reviewed articles, including 7 first-in-literature reports. He holds accreditations from the European Association of Cardiothoracic Surgery.

Education and Expertise

Ankara University Faculty of Medicine - Medical Education

Gazi University Faculty of Medicine Department of Internal Medicine - Internal Medicine - Specialization

Gazi University Faculty of Medicine Department of Hematology - Hematology - Subspecialty

Duke University Bone Marrow Transplantation Center - Stem Cell Transplantation Training

Fred Hutchinson Cancer Research Center Seattle - Stem Cell Transplant Training

Experience

Duke University-Durham North Carolina Bone marrow transplantation program 2001, cord blood transplant

Fred Hutchinson Cancer Research Center Bone Marrow Transplantation program Seattle 2002, unrelated stem cell transplant

Founder and manager of Gazi University Faculty of Medicine Adult Stem Cell Transplant Unit 2003-2014

Gazi University Faculty of Medicine, Head of Hematology Department 2008-2014

Gazi University Faculty of Health Sciences Dean (founder) 2008-2012

Professional Memberships

Turkish Hematology Association





Bilimsel Yayınları

1.    Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.
    Bone Marrow Transplant. 2017 Jul;52(7):1081. doi: 10.1038/bmt.2017.86
2.    Deger SM, Erten Y, Suyani E, Aki SZ, Ulusal Okyay G, Pasaoglu OT, Pasaoglu H, Arinsoy T, Turkoz Sucak G. Early Diagnostic Markers for Detection of Acute Kidney Injury in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Exp Clin Transplant. 2017 Apr 14. doi: 10.6002/ect.2016.0161. [Epub ahead of print]
3.    Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Meltem Akay O, Gülbas Z, Nahi H, Plesner T, Snowden JA, Timurağaoğlu A, Dechow T, Lang A, Tuğlular T, Drach J, Armbrecht G, Potamianou A, Couturier C, Olie RA, Feys C, Allietta N, Terpos E. Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study. Br J Haematol. 2017 Jul;178(1):61-71. doi: 10.1111/bjh.14637. Epub 2017 Apr 6
4.    Özkurt ZN, Sucak GT, Akı ŞZ, Yağcı M, Haznedar R.Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Cancer Invest. 2017 Mar 16;35(3):195-201. 
5.    Aslan D, Türköz-Sucak G, Percy MJ. Recessive congenital methemoglobinemia in immediate generations.Turk J Pediatr. 2016;58(1):113-115
6.    Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant. 2017 Feb;52(2):209-215. Erratum in: Bone Marrow Transplant. 2017 Jul;52(7):1081.
7.    Pamukcuoglu M, Acar K, Celik B, Akyurek N, Pepeler MS, Sucak GT. Peripheral and bone marrow CD34+ cell levels on chronic myeloproliferative disease. Hematology. 2017 Mar;22(2):74-80. 
8.    van Gorkom G, Finel H, Giebel S, Pohlreich D, Shimoni A, Ringhoffer M, Sucak G, Schaap N, Dreger P, Sureda A, Schouten HC. Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas. J Clin Apher. 2016 Sep 10. doi: 10.1002/jca.21506. [Epub ahead of print]
9.    Necchi A, Miceli R, Bregni M, Bokemeyer C, Berger LA, Oechsle K, Schumacher K, Kanfer E, Bourhis JH, Massard C, Laszlo D, Montoro J, Flechon A, Arpaci F, Secondino S, Wuchter P, Dreger P, Crysandt M, Worel N, Kruger W, Ringhoffer M, Unal A, Nagler A, Campos A, Wahlin A, Michieli M, Sucak G, Donnini I, Schots R, Ifrah N, Badoglio M, Martino M, Raggi D, Giannatempo P, Rosti G, Pedrazzoli P, Lanza F. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. Bone Marrow Transplant. 2016 Mar;51(3):384-90. 
10.    Cahu X, Labopin M, Giebel S, Aljurf M, Kyrcz-Krzemien S, Socié G, Eder M, Bonifazi F, Bunjes D, Vigouroux S, Michallet M, Stelljes M, Zuckerman T, Finke J, Passweg J, Yakoub-Agha I, Niederwieser D, Sucak G, Sengeløv H, Polge E, Nagler A, Esteve J, Mohty M; Acute Leukemia Working Party of EBMT. Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT. Bone Marrow Transplant. 2016 Mar;51(3):351-7. 
11.    Marchand T, Lamy T, Finel H, Arcese W, Choquet S, Finke J, Huynh A, Irrera G, Karakasis D, Konopacki J, Lambert J, Michieli M, Schouten HC, Schroyens W, Sucak G, Tischer J, Vandenberghe E, Dreger P. Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. Leukemia. 2016 May;30(5):1201-4
12.    Köktürk N, Yıldırım F, Aydoğdu M, Akı ŞZ, Yeğin ZA, Özkurt ZN, Suyanı E, Kıvılcım Oğuzülgen İ, Türköz Sucak G. Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels? Turk J Haematol. 2016 Mar 5;33(1):34-40. 
13.    Barğı G, Güçlü MB, Arıbaş Z, Akı ŞZ, Sucak GT. Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial. Support Care Cancer. 2016 Feb;24(2):647-659
14.    Camcıoğlu B, Boşnak-Güçlü M, Karadallı MN, Akı ŞZ, Türköz-Sucak G. The Role of Inspiratory Muscle Training in Sickle Cell Anemia Related Pulmonary Damage due to Recurrent Acute Chest Syndrome Attacks.Case Rep Hematol. 2015;2015:780159. doi: 10.1155/2015/780159. Epub 2015  Apr 28.
15.     Fox CP, Boumendil A, Schmitz N, Finel H, Luan JJ, Sucak G, Blaise D, Finke J, Pflüger KH, Veelken H, Gorin NC, Poiré X, Ganser A, Dreger P, Sureda A. High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in Western patients; a study from the European Society for Blood and Marrow Transplantation. Leuk Lymphoma. 2015 Apr 22:1-20. 
16.    Akı ŞZ, Suyanı E, Cengiz M, Özenirler S, Elbeğ Ş, Paşaoğlu H, Sucak GT. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation. Biol Blood Marrow Transplant. 2015 May;21(5):948-953.
17.    Beksaç M, Waage A, Bringhen S, Kristinsson SY, Sucak G, Gimsing P, Giulia L, Tuglular TF, Juliusson G, Turesson I, Palumbo A. Does Low Molecular Weight Heparin Influence The Anti-Myeloma Effects Of Thalidomide? A Retrospective Analysis On Data From The GIMEMA, Nordic and Turkish Myeloma Study Groups Acta Haematologica 2015 Mar 24;133(4):372-380
18.    Pepeler MS, Acar K, Güzel Tunçcan Ö, Uluoğlu Ö, Kalkancı A, Atalar H, Kılıç K, Türköz Sucak G. A proven case of cutaneous rhizopus infection presenting with severe limb pain very soon after induction treatment in a patient with acute lymphoblastic leukemia. Case Rep Hematol. 2015;2015:285360. doi: 10.1155/2015/285360. Epub 2015 Feb 15.
19.    Yegin ZA, Iyidir OT, Demirtaş C, Suyanı E, Yetkin I, Paşaoğlu H, Ilhan C, Sucak GT. The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders. J Endocrinol Invest. 2014 Sep 23. [Epub ahead of print]
20.    Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L, Blaise D, Milpied N, Sucak G, Sureda A, Thomson K, Vandenberghe E, Vitek A, Dreger P. Allogeneic and Autologous Stem Cell Transplantation for hepatosplenic T cell lymphoma: A retrospective study of the EBMT Lymphoma Working party. Leukemia. 2014 Sep 19. doi: 10.1038/leu.2014.280. [Epub ahead of print]
21.    Salihoglu A, Elverdi T, Karadogan I, Paydas S, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin Z, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Göker H, Başlar Z, Ferhanoglu B. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Ann Hematol. 2014 Sep 18. [Epub ahead of print]
22.    Aygencel G, Türkoğlu M, Türköz Sucak G, Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care. 2014 Aug;29(4):618-26.
23.    Pamukçuoğlu M, Emmez H, Tunçcan OG, Oner AY, Cırak MY, Senol E, Sucak GT. Brain abscess caused by Nocardia cyriacigeorgica in two patients with multiple myeloma: novel agents, new spectrum of infections. Hematology. 2014 Apr;19(3):158-62. 
24.    Kadir Acar, Şahika Zeynep Akı, Zübeyde Nur Özkurt, Gülendam Bozdayı, Seyyal Rota, Gülsan Türköz Sucak Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors Turk J Haematol. 2014 Sep 5;31(3):276-285
25.    Abdülkerim Yıldız, Merih Kızıl Çakar, Elif Suyanı, Gülsan Türköz Sucak A Systemic Lupus Erythematosus Patient with Isolated Neutropenia and Diminished Expression of CD55 and CD59 Similar to Paroxysmal Nocturnal Hemoglobinuria doi: 10.4274/Tjh.2013.0318   Pages 323 – 324
26.    Suyanı E, Sucak GT, Akyürek N, Sahin S, Baysal NA, Yağcı M, Haznedar R. Tumor-associated macrophages as a prognostic parameter in multiple myeloma. Ann Hematol. 2013 May;92(5):669-77
27.    Akyol A, Nazlıel B, Batur Caglayan HZ, Oner Y, Sucak GT. Recurrent Transient Ischemic Attacks in a Patient with POEMS Syndrome. Case Rep Neurol Med 2014:158471
28.    Boyacı N, Aygencel G, Turkoglu M, Yegin ZA, Acar K, Sucak GT. The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis. Hematology. 2014 Sep;19(6):338-45
29.    Merve Pamukcuoğlu, Kadir Acar, Nalan Akyürek, Gülsan Türköz Sucak. Non-Leukemic Granulocytic Sarcoma Presenting with Multiple Skin Nodules and a Retroperitoneal Mass. Turk J Hematol 2013;30:81-82
30.    Merve Pamukçuoğlu, Kadir Acar, Nalan Akyürek, Gülsan Türköz Sucak A Rare Case of Acute Leukemia Relapsing with a Granulocytic Sarcoma Causing Ectopic Pregnancy Indian Journal of Hematology and Blood Transfusion April 2013
31.    Keser I, Suyani E, Aki SZ,  Sucak AG. The positive impact of regular exercise program on stem cell mobilization prior to autologous stem cell transplantation. Transfus Apher Sci. 2013 Jul 6. doi:pii: S1473-0502(13)00205-X. 10.1016/j.transci.2013.06.007. [Epub ahead of print]
32.    Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Ozdemir E, Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M, Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC.  Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study. Acta Haematol 2013 Jun 19;130(3):199-205.
33.    Yaşar DG, Suyanı E, Özenirler S, Sucak GT. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.Transplant Proc. 2013 Mar;45(2):833-4.
34.    Keser I, Suyani E, Yosmaoglu HB, Aki SZ, Sucak AG. Acute physiological responses to physiotherapy applications pre and post autologous stem cell transplantation: an experimental study. Hematology. 2014 Apr;19(3):136-40.
35.    Yağcı M, Yegin ZA, Akyürek N, Kayhan H, Ozkurt ZN, Sucak GT, Haznedar R. TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic lymphocytic leukemia. Leuk Res. 2013 Jun;37(6):665-70.
36.    Sucak GT, Cakar MK, Suyanı E, Akı Z, Altındal SE, Acar K. Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey. Hematology. 2013 Sep;18(5):269-76.
37.    Türkoğlu M, Erdem GU, Suyanı E, Sancar ME, Yalçın MM, Aygencel G, Akı Z, Sucak G.Acute respiratory distress syndrome in patients with hematological malignancies. Hematology. 2013 May;18(3):123-130.
38.    Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT. Bone Marrow Transplant. 2013 Jun;48(6):878-9.
39.    Çakar MK, Suyani E, Sucak GT, Altindal Ş, Aki SZ, Acar K, Yağci M, Rota S, Özenirler S. HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey. Ann Hematol. 2013 Mar;92(3):395-402.
40.    Akı ŞZ, Suyanı E, Bildacı Y, Çakar MK, Baysal NA, Sucak GT. Prognostic role of pre-transplantation serum C-reactive protein levels in patients with acute leukemia undergoing myeloablative allogeneic stem cell transplantation. Clin Transplant. 2012 Sep-Oct;26(5):E513-2.
41.    Akı SZ, Pamukçuoğlu M, Bağrıaçık Ü, Sucak GT. Encephalopathy: an unusual neurologic complication of autologous hematopoietic stem cell transplant in patients with multiple myeloma with renal failure.Leuk Lymphoma. 2013 Apr;54(4):894-6.
42.    Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2013 Mar;98(3):339-45.
43.    Palumbo A, Waage A, Hulin C, Beksac M, Zweegman S, Gay F, Gimsing P, Leleu X, Wijermans P, Sucak G, Pezzatti S, Juliusson G, Pégourié B, Schaafsma M, Galli M, Turesson I, Kolb B, van der Holt B, Baldi I, Rolke J, Ciccone G, Wetterwald M, Lokhorst H, Boccadoro M, Rodon P, Sonneveld PSafety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials. Haematologica. 2013 Jan;98(1):87-94.
44.    Aydoğdu M, Ozyilmaz E, Köktürk N, Yeğin ZA, Özkurt ZN, Aki ZS, Sucak G. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation? Minerva Med. 2012 Jun;103(3):189-98.
45.    Suyanı E, Altındal Ş, Akı Ş, Sucak GT. Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning? Clin Transplant. 2012 Mar-Apr;26(2):E85-6.
46.    Sucak GT, Yaşar DG, Yegin ZA, Ergün MA, Ozkurt ZN, Aki ŞZ, Güntekin S. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2012 Aug;91(8):1281-7.
47.    Suyanı E, Sucak GT, Erten Y, Cakar MK, Ulusal G, Yağcı M, Haznedar R. Evaluation of multiple myeloma patients presenting with renal failure in a university hospital in the year 2010. Ren Fail. 2012;34(2):257-62.
48.    Sucak GT, Suyanı E, Baysal NA, Altındal Ş, Çakar MK, Akı ŞZ, Yeğin ZA, Şanlıer N.The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning. Int J Hematol. 2012 Jan;95(1):95-101.
49.    Bağrıaçık EU, Yaman M, Haznedar R, Sucak G, Delibasi T. TSH-induced gene expression involves regulation of self-renewal and differentiation-related genes in human bone marrow-derived mesenchymal stem cells.J Endocrinol. 2012 Feb;212(2):169-78.
50.    Elif Suyanı, Zeynep Akı, Zeynep Arzu Yeğin, Gülsan Türköz Sucak. Bortezomib-Associated Severe Orthostatic Hypotension and Hyponatremia Turk J Hematol 2012; 29: 301-302.
51.    Zeynep Arzu Yegin, Gülsan Türköz Sucak, Gonca Erbaş, Münci Yağcı ARA-C associated pulmonary toxicity. Turk J Hematol 2011; 28: 81-3.
52.    Turkoglu M, Mirza E, Tunçcan OG, Erdem GU, Dizbay M, Yağcı M, Aygencel G, Türköz Sucak G. Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality. J Crit Care. 2011 Oct; 26(5):460-7.
53.    Akı SZ, Paşaoğlu H, Yeğin ZA, Suyanı E, Demirtaş CY, Ozkurt ZN, Yağcı M, Sucak GT. Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.Hematology. 2011 Sep;16(5):284-90.
54.    Yenicesu I, Sucak G, Dilsiz G, Akı SZ, Yeğin ZA. Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion. Indian J Hematol Blood Transfus. 2011 Sep;27(3):146-51.
55.    Tunçcan ÖG, Aki ŞZ, Akyürek N, Sucak G, Şenol E. Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.J Infect Dev Ctries. 2011 May 28;5(5):406-9.
56.    Rota S, Fidan K, Bozdayı G, Dalgıç A, Fidan I, Sucak G, Müderris T. [Investigation of BK and JC virus DNA positivities by real-time polymerase chain reaction in the clinical samples of patients with high risk].Mikrobiyol Bul. 2011 Apr;45(2):280-7.
57.    Suyanı E, Yağcı M, Sucak GT. Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome. Acta Haematol. 2011;126(4):199-201.
58.    Sucak GT, Özkurt ZN, Suyanı E, Yaşar DG, Akdemir ÖÜ, Akı Z, Yeğin ZA, Yağcı M, Kapucu ÖL. Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival. Ann Hematol. 2011 Nov;90(11):1329-36.
59.    Ljungman P,  de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H, Gonzalez-Vicent M, Espigado I, Halter J, Martino R, Mohty B, Sucak G, Ullmann AJ, Vázquez L, Ward KN, Engelhard D; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation; Infectious Complications Subcommittee, Spanish Group of Haematopoietic Stem-cell Transplantation. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011 Aug;96(8):1231-5.
60.    Sucak GT, Aki SZ, Yüzbaşioğlu B, Akyürek N, Yağci M, Bağriaçik U, Haznedar R. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant. Leuk Lymphoma. 2011 Jul;52(7):1281-9.
61.    Yegin ZA, Paşaoğlu H, Aki SZ, Özkurt ZN, Demirtaş C, Yağci M, Acar K, Sucak GT. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation.Int J Lab Hematol. 2011 Aug;33(4):414-23.
62.    Haznedar R, Akı ŞZ, Akdemir ÖÜ, Özkurt ZN, Çeneli O, Yağcı M, Sucak GT, Unlü M. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma. Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1046-53.
63.    Suyani E, Aki Z, Güzel Ö, Altindal S, Senol E, Sucak G.H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving.Transpl Infect Dis. 2011 Apr;13(2):208-12.
64.    Sucak A, Acar K, Celen S, Danisman N, Sucak GT. Outcome of pregnancies in women with thrombophilic disorders.J Obstet Gynaecol. 2010;30(8):847-51.
65.    Suyanı E, Sucak GT, Akı ŞZ, Yeğin ZA, Özkurt ZN, Yağcı M. Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT. Ann Hematol. 2011 Jun;90(6):685-91.
66.    Beksaç M, Haznedar R, Firatli-Tuğlular T, Özdogu H, AydoĞdu I, Konuk N, Sucak G, Kaygusuz I, Karakus S, Kaya E, Ali R, Gulbas Z, Ozet G, Goker H, Undar L. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. Eur J Haematol. 2011 Jan;86(1):16-22.
67.    Sucak G, Suyanı E, Özkurt ZN, Yeğin ZA, Aki Z, Yagci M. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance? Hematol Oncol. 2010 Dec;28(4):180-4.
68.    Ozyilmaz E, Aydoğdu M, Sucak G, Akı ŞZ, Özkurt ZN, Yeğin ZA, Köktürk N. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplant. 2010 Oct;45(10):1528-33.
69.    Tunçcan OG, Yegin ZA, Ozkurt ZN, Erbaş G, Akı SZ, Senol E, Yağcı M, Sucak G. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates.Int J Infect Dis. 2010 Sep;14 Suppl 3:e 104-7.

Education, Awards and Certifications

• Inter High School Project Competition, Third in Turkey, Using the activated carbon

obtained from waste batteries as ion and gas trap,Scientific and Technological

Research Council of Turkey (TUBİTAK)-2009

• Tokat Science High School – 2010

• Istanbul University School of Medicine(Graduted with distinction) – 2016

• Sarıyer State Hospital(Emergency Medicine) 2017

• Animal Research Certificate – January 2019

• Microsurgery Certificate- May 2019

• Medical statistics certificate- July 2019

• Bagcılar Research and Training Hospital, Department of Plastic, Reconstructive and

Aesthetic Surgery(Residency) 2017-2022

• Universita Campus Bio-Medico, Department of Plastic,Reconstructive and Aesthetic

Surgery Rome/Italy(Microsurgery Fellowship) 2022-

• Erzurum State Hospital,Erzurum/Turkey 2022-2024 

Medipol Acıbadem District Hospital  (Current)

Dr. Mustafa Ibas is an ENT specialist. He has clinical experience in childhood ENT diseases, rhinoplasty, endoscopic sinus surgery, ear diseases, hearing loss, head and neck surgery, salivary gland diseases, and maxillofacial trauma surgery. Dr. Ibas worked as an ENT specialist at Ankara Etimesgut Sait Ertürk State Hospital from 2023 to 2024. He also served at Mardin Midyat State Hospital from 2022 to 2023. He completed his assistant physician training at Health Sciences University Ankara Training and Research Hospital between 2017 and 2022.

Dr. Ibas has published several peer-reviewed articles. His research covers topics such as preauricular iatrogenic epidermoid cysts, dermatofibrosarcoma protuberans, the use of probiotics in otitis media, and the anti-inflammatory effects of naringenin in otitis media. He earned his medical degree from Necmettin Erbakan University Meram Faculty of Medicine.

Place and Date of Birth

• 1972

Language Skills

• English

Education and Experience

• Hacettepe University, School of Medicine (Undergraduate Education)
• Bahçeşehir University, School of Medicine (Education Commission Membership)

Memberships

• TOD (Turkish Society of Ophthalmology)
  
  International Articles

ULUOCAK N., PARLAKTAS BS., DENİZ FE, ERDEMİR F., KOSEOGLU RD., GEDAR OM. ORBITAL METASTASIS OF PROSTATE CANCER: A CASE REPORT. KAOHSIUNG J MED SCI. 2007;23:199–202.

Gedar (Totuk) OM, ARI DE, AYKAN Ü. Anesthetıc Management in Glaucoma Surgery. ARC Journal of Anesthesiology Volume 1, Issue 3, 2016, PP 9-18

ISSN No. 2455-9792 (Online) http://dx.doi.org/10.20431/2455-9792.0103002

www.arcjournals.org.

International Reports

TOYGAR B, GORGUN E, GEDAR M, COSKUNSEVEN E, ARSLAN E.REFRACTIVE LENS EXCHANGE WITH THE DIFFRACTIVE TECNIS MULTIFOCAL IOL: LONG-TERM FOLLOW-UP. XXIV CONGRESS OF THE ESCRS. 9-13 SEPTEMBER 2006, LONDON. FREE PAPER. ABSTRACT BOOK P.151-152.

TOYGAR B, GORGUN E, COSKUNSEVEN E, ARSLAN E, GEDAR M. TORIC PHAKIC INTRAOCULAR LENS IMPLANTATION: LONG-TERM RESULTS. XXIV CONGRESS OF THE ESCRS. 9-13 SEPTEMBER 2006, LONDON. FREE PAPER. ABSTRACT BOOK P.152.

GEDAR M, TOYGAR B, COSKUNSEVEN E, ARSLAN E. COMPARISON OF FLAP THICKNESS ACCURACY USING HANSATOME® XP MICROKERATOME AND INTRALASE FEMTOSECOND FS2 AND FS30 LASERS FOR LASIK. XXIV CONGRESS OF THE ESCRS. 9-13 SEPTEMBER 2006, LONDON

 DRY EYE, TREATMENTS. SEEOS 5TH CONGRESS. CRCRS – 4TH OPHTHALMOLOGİC SCHOOL – 16-18 MAY 2008. INVITED SPEAKER.

 TRANSCANALICULAR ENDOSCOPIC DCR. SEEOS & BSOS CONGRESS- 19-22 MAY 2011. INVITED SPEAKER.

 EARLY EXPERIENCE WITH A NEW DIFFRACTIVE REFRACTIVE MULTIFOCAL IOL. TOYGAR B, YABASKIZILOGLU O, TOYGAR O, HACIMUSTAFAOGLU AM, GEDAR OM. ASCRS•ASOA SYMPOSİUM & CONGRESS MAY 6-10, 2016.


 

ACADEMIC CAREER SUMMARY

Degree: Bachelor's
Field: Medicine
University: Atatürk University
Year: 2001

Degree: Master's
Field: Medicine
University: Atatürk University
Year: 2001

Specialization/Doctorate: Internal Medicine/Gastroenterology
University: İnönü University
Year: 2012

Associate Professorship: Gastroenterology
University: İnönü University
Year: 2018

Foreign Language: English, 67.5, 2007

H-index (WoS/Google): 8/10

Impact Factor: 8.1577

Key Research Work:
“Does apocynin increase liver regeneration in the partial hepatectomy model?” Yılmaz Bilgiç, Burhan Hakan Kanat, Onural ÖZHAN, Azibe YILDIZ, Zeynep AKSUNGUR, Mehmet Erman ERDEMLİ, Nigar VARDI, Yusuf TÜRKÖZ, Sami AKBULUT, Adem KÖSE, Hakan PARLAKPINAR. Turkish Journal of Medical Sciences, 2023 (53), 1-12 Q3.

Declared Project Title, Year:
K.3.6. “Investigation of the Effects of Vinpocetine in Sepsis Created by Cecal Ligation and Puncture in Rats” (Principal Investigator), 2023

International Experience:
Advanced Endoscopy Training, Anam Hospital, South Korea (3 months, 2016)
Advanced ERCP Course, Olympus Training Center, Hamburg (2017)

ADMINISTRATIVE POSITIONS

• Institution: İnönü University Turgut Özal Medical Center
  City: Malatya
  Position: Assistant Chief Physician
  Period: 2021 - 2024

EDUCATION

Ankara City Hospital Plastic, Reconstructive and Aesthetic Surgery (Specialization Training) (2019-2020)

Ankara Numune Training and Research Hospital. Plastic,

Reconstructive and Aesthetic Surgery (Specialization Training) (2015-2019)

Hacettepe University Faculty of Medicine, English (2008-2014)

Ankara Science High School (2004-2008)

WORK EXPERIENCE 

Gelibolu State Hospital (2014-2015)

Ankara NumuneTraining and Research Hospital, Plastic, Reconstructive and Aesthetic Surgery

Clinic (2015-2019)

Ankara City Hospital, Plastic, Reconstructive and Aesthetic Surgery

Clinic (2019-2020)

Ankara Di§kapi Yildirim Beyazit Training and Research Hospital, Plastic, Reconstructive and Aesthetic Surgery Clinic (2020-2022)

Elixirmed Clinic (2022 - until now)

Plastic, Reconstructive, and Aesthetic Surgery Clinic

SCIENTIFICIN STITUTI ONS

Turkish Plastic, Reconstructive, and Aesthetic Surgery Association

CE RTI FI CAT IONS

Fellow of European Board of Plastic Reconstructive and Aesthetic Surgery (EBOPRAS)

Dr. Derya Can has been an Assistant Professor of Dermatology at Medipol Health Group since 2021. She diagnoses and treats diseases of the skin, hair, nails, and mucosa. Her areas of expertise include eczema, atopic dermatitis, acne, psoriasis, sexually transmitted infections, warts, herpes, shingles, and fungal infections.

Dr. Can manages both benign and malignant skin tumors. She also treats hair and nail disorders, vitiligo, and other common skin conditions. She performs advanced procedures such as hair transplantation and PRP therapy for hair loss.

Dr. İlhami Soykan Barlas was born in the year 1977 in Istanbul Moda. He is graduated from Kadıköy Anadolu High School and Cerrahpaşa Faculty of Medicine. He was awarded the title of General Surgery Specialist after completing his general surgery specialization in Okmeydanı Training and Research Hospital in the year 2008. 

He went to Scotland 2 times in the years 2006-2007 and received advanced laparoscopic education. He awarded with ‘Certificate of Appreciation’ by the Ministry of Health of the Republic of Turkey in the year 2009 for his contributions to the establishment of Dr. Lütfi Kırdar Training and Research Hospital Burn Center and for his related works. 

After completing his compulsory service at Kastamonu İnebolu State Hospital between the years 2009-2011, resigned from his duty at the state owned institutions, returned to Istanbul and started to work in private sector. He has been working as kidney transplant and general surgery specialist in Florence Nightingale group of hospitals since the year 2013. Since the year 2017, he has been serving as academic Doctor Lecturer in Faculty of Medicine of Demiroğlu Science University. He has more than 20 articles published in national and international journals in general surgery and kidney transplant and more than 30 proceedings that are submitted in national and international congresses. 

He also has been the book editor and chapter author on kidney transplant and he also has been chapter author in various surgery books. Dr Soykan Barlas has been awarded the title ‘General Surgery Associate Professor’ in the year 2020. Currently, he has been working within the organization of Medical Park Group of Hospitals .

 EXPERIENCES 

 İstanbul Okmeydanı Training and Research Hospital 2003-2008 (Specialization Education ) 

 İstanbul Lütfi Kırdar Kartal Training and Research Hospital 2009 

 İnebolu State Hospital 2009-2011 (Compulsory Service Duty) 

 Private Hospitalium Şişli Hospital 2012-2013 

 Şişli Florence Nightingale Hospital Kidney and Pancreas Transplant Center 2013-2020 

 Demiroğlu Science University Faculty of Medicine Surgery Department Lecturer 2017- Present 

 İstanbul Florence Nightingale Hospital Kidney and Pancreas Transplant Center 2020- Present 

 Private Osmanoğlu Hospital Şişli 2020-2022 Medical Park Göztepe Hospital 2022- present.

SCIENTIFIC ARTICLES 

1.Soykan Barlas,ArzuAkan,YavuzEryavuz,GirayYavuz,SedatKamalı,Gülçin Kamalı: PrimaryHydatidosis of thegluteusmuscle:Report of a caseandreview of theliterature. Ind JSurg.2016; 78(2): 161–162. 

2.Metin Kement, Hakan Ahmet Acar, İlhami Soykan Barlas, Nihat Aksakal, Cem Gezen, Uygar Düzci, Mustafa Öncel: Clinical evaluation of a temporaryfecalcontainmentdevicefornonsurgicalfecaldiversion in perinealburns. Ulus Trauma Emergency Surgery Journal. 2011; 17(2): 123-127 

3.Bilgin Y, Hot S,BarlasIS,AkanA,Eryavuz Y:Short andlongtermresults of harmonicscalpelhemorrhoidectomyversusstaplerhemorrhoidopexy in treatment of hemorrhoidaldisease. Asian J Surg. 2015;38(4):214-9. 

4.Sinangil A, Celik V, Barlas S, Sakaci T, Koc Y, Basturk T, Akin EB, Ecder T. NewOnsetDiabetesAfterKidneyTransplantationandPretransplantHypoma gnesemia.ProgTransplant. 2016 Mar;26(1):55-61. doi: 10.1177/1526924816633949. 

5.Sinangil A, Celik V, Barlas S, Altunrende F, Akin EB, Ecder T. CalcifiedDouble J StentafterSequentialLiverandRenalTransplantationAssociatedtoprim aryOxalosis: Case Report. BANTAO journal, 2015;13(2), 97-99. 

6.Sinangil A, Celik V, Barlas S, KuskuCabuk F, Akin EB, Ecder T. A veryraretumor in a renaltransplantdonorcandidate: primarymesentericneuroendocrinetumor.InternationalJournal Of AdvancesIn Case Reports, 2015;2(4):244-249 

7.Sinangil A, Celik V, Barlas S, Akin EB, Ecder T. Shouldtransplantureter be stentedroutinelyor not?EurRevMedPharmacolSci. 2014;18(23):3551-6. 

8.Sinangil A, Celik V, Barlas S, Koc Y, Basturk T, Sakaci T, Akin EB, Ecder T. Theincidence of newonsetdiabetesaftertransplantationandrelatedfactors: Singlecenterexperience. Nefrologia, 2017;37(2):181-188. 

9.Akin EB, Aydogdu I, Barlas IS. Introducing RobotAssistedLaparoscopicDonorNephrectomyAfterExperienceInHandAssistedRetroperitoneoscopicApproach. TransplantProceedings 2019;51, 2221-222. 

10. Barlas IS, Aydogdu I, Sinangil A, Atan Ucar Z, Koc Y, Sardogan C, Akin EB. IncisionalComplicationsandCosmetic Evaluation AfterHand-AssistedRetroperitoneoscopicDonorNephrectomy. TransplantProceedings 2019; 51, 2215-2220. 

11. Barlas IS, Aydogdu I, Sinangil A, Atan Ucar Z, Koc Y, Ecder T, Akin EB. HandAssistedNephretomyPredisposesIncisionalHerniationInObeseL ivingDonors. TransplantProceedings 2019; 51, 2210-2214. 

12.Sinangil A, Atan Ucar Z, KocY, Barlas IS, Abouzahir S,Ecder ST, Akin EB. TheOutcome of DesensitizationTherapy in Immunologically High-risk KidneyTransplantation: Single-Center Experience. TransplantProceedings 2019; 51, 2268-2273 

13.GodeOguten E, Barlas IS, Akin EB. MentalDistressSymptomsand Life SatisfactionamongLivingKidneyDonors: FrequencyandAssociationwithSubjectiveEvaluations. TransplantProceedings 2019; 51, 2232-2236 

14. Atan Ucar Z,Sinangil A, Koc Y, Barlas IS, AbouzahirS, Ecder T, Akin EB. TheClinicalPrognosis Of TheRenalRetransplantPatients: A Single Center Experience. TransplantProceedings 2019;51, 2274- 2278. 

15. Barlas IS, Demir M, Akın EB. A single-center nineyearexperience in pediatrickidneytransplantation. Cumhuriyet MedicalJournal 2020; 42 (1), 126-135

Spinal neurosurgeon

Dr. Murat Ayhan is an Associate Professor of Medical Oncology since 2023. He is an expert in breast, lung, colorectal, gynecological, and urogenital cancers. He focuses on modern cancer treatments such as immunotherapy, smart drugs, targeted therapies, and molecular oncology. Dr. Ayhan provides personalized care based on the latest scientific research.

He is the principal investigator in several global Phase II and III oncology trials. These include studies on GDC-9545, Palbociclib, Atezolizumab, and Apalutamide. Dr. Ayhan has published over 25 articles in international journals. His research covers COVID-19’s effects on cancer patients, drug desensitization, and real-world treatment results.

He is an active member of ESMO and TTOD. Dr. Ayhan has also contributed to oncology reference books on tyrosine kinase inhibitors and oncological emergencies. His work helps advance cancer care for future generations.

Dr. Gulsen Kose is a respected pediatric neurologist with over 40 years of experience. She has worked at leading Turkish institutions, including Hacettepe University and Liv Hospital. In 1993, she established the Pediatric Neurology Department at Ankara Pediatric Health and Hematology Oncology Hospital. This was an important step forward for pediatric care in Turkey.

Dr. Kose specializes in neurodegenerative, neurometabolic, and rare acquired neurological diseases. She has special expertise in Autoimmune Encephalitis and SSPE. Her work has improved the lives of thousands of children, especially those with epilepsy and cerebral palsy. She is a founding member of the Turkish Society of Developmental Pediatric Neurology. She also belongs to five major international pediatric neurology societies.

Dr. Kose has served as clinic chief, associate professor, and service supervisor. Her leadership has helped shape care standards and improve specialist training. She is recognized as a leader in pediatric neurology.

TAHA ELKHATROUSHI
Otorhinolaryngologist (ENT Specialist)
⸻

PUBLICATIONS
    •    Comparison of different surgical branches’ perspectives on 3D printing technology. 16th Turkish Rhinology Congress, 2022.
    •    Olfactory and Taste Dysfunction During the COVID-19 Pandemic: A Multicenter Study. 43rd National ENT Congress, 2022.
    •    Virtual Modeling and 3D Printing in ENT Surgery. 8th ENT Spring Meeting, 2023.
    •    EuroSurg Collaborative. Body mass index and complications following major gastrointestinal surgery: a prospective, international cohort study and meta-analysis. Colorectal Disease, 2018.
    •    The Use of Three-Dimensional Printed Technology for Mandibular Reconstruction in a Rare Case of Giant Odontogenic Myxofibroma. Journal of Craniofacial Surgery, 2021.

⸻

WORK EXPERIENCE

2019–2024
Istanbul University - Cerrahpaşa Medical Faculty
Department of Otorhinolaryngology

⸻

EDUCATION

2010–2016
Istanbul University - Istanbul Faculty of Medicine

June 2016
University of Iowa, Department of Otolaryngology – Head and Neck Surgery
Research Assistant

September 2023
University of Texas Medical Branch, Department of Otolaryngology – Head and Neck Surgery
Observership

⸻

COURSES & CERTIFICATIONS
    •    ECFMG Certification (USMLE Step 1-2-3)
    •    Laboratory Animal Use Certificate, Bezmialem Vakıf University – 2021
    •    Face-to-Face Cadaver Course – 2023

⸻

CONGRESSES & MEETINGS
    •    17th National and 2nd International Facial Plastic Surgery Congress / İzmir – 2023
    •    Nosecraft Essentials of Rhinoplasty – 2024
    •    Structure-Preservation Rhinoplasty Conference – 2024

⸻

AWARDS
    •    1st Prize for the presentation: Virtual Modeling and 3D Printing in ENT Surgery
8th ENT Spring Meeting, 2023

Dr. Cem Çerkez is a board-certified plastic surgeon. He graduated from Ankara University School of Medicine in 2005. He completed his specialization in plastic surgery in 2012. In 2015, he founded Renovium Clinic. Dr. Çerkez is dedicated to providing high-quality patient care and advancing techniques in plastic, reconstructive, and aesthetic surgery.

During his residency, Dr. Çerkez was actively involved in scientific research. He continues to develop his skills by attending national and international conferences. He is a respected member of the Turkish Society of Plastic, Reconstructive and Aesthetic Surgery and the Turkish Society of Aesthetic Plastic Surgeons.

Dr. Hala Ibrahim Elgmati is a skilled hair transplant surgeon with over 15 years of experience. She focuses on Follicular Unit Extraction (FUE) and has completed more than 1,000 FUE hair transplants.

Dr. Elgmati received medical training in both Libya and the United States. She is a member of the Royal College of Physicians and the British Medical Association in the UK. Her memberships reflect her dedication to high standards in hair restoration.